DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Sandborn WJ, Feagan BG, Rutgeerts P. , et al; GEMINI 2 Study Group.
Vedolizumab as induction and maintenance therapy for Crohn's disease.
N Engl J Med 2013;
369 (08) 711-721
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.